Developing Microbiome-Based Therapeutics & Novel Approaches to Metagenomic Research
Posted 11th January 2019 by Kieran Chambers
As the understanding of the role that bacterial ecosystems play within human and animal health deepens, so has the increase in the amount of research and companies focusing on the Microbiome. If you were unable to attend the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Edward Burd, Kathy McCoy & Jan Majta available.
Skin Microbiome: Cosmeceutical Development, Sample Collection & Storage and Patient Stratification
Posted 2nd January 2019 by Kieran Chambers
Whilst microbiome as a whole is gaining traction, developments in wound healing, skin ageing and inflammation have garnered a wider understanding of the skin microbiome in health and disease. If you were unable to attend the dedicated Skin Microbiome track at the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Madhuri Jasti, Mark Wilson and Kausar Malik available here.
A microbiome solution for type 1 diabetes?
Posted 28th December 2018 by Jane Williams
This article is republished with kind permission from Biovox. The original article can be found here.
Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a global effort, the TEDDY study, to understand what causes the disorder and pave the way for effective interventions. A number of analyses emerging from TEDDY are now bringing into focus the role of the microbiome in T1D. We now ask the question: could the microbiome be the key to intercepting and preventing T1D?
The Best Microbiome and Probiotics Articles of 2018
Posted 24th December 2018 by Kate Barlow
2018 has been another big year for the microbiome and probiotics. Investment is at an all-time high with the global probiotics market expected to grow with a compound annual growth rate of 6.5% over the forecast period of 2018-2024, while the microbiome market is predicted to grow from $235.8 million in 2018 to $521.23 million by 2022. [1][2]
Biobanking, Therapeutics & Probiotics in Microbiome Research
Posted 19th December 2018 by Kieran Chambers
As the world becomes increasingly aware of the important role that different bacterial ecosystems play with regards to human and animal health, there is a growing wealth of research coming out of the microbiome industry. Kristina Campbell & Marilyn White, of KC Microbiome, conducted these interviews at the Microbiome R&D and Business Collaboration Forum: USA.
A personal translation of Microbiome Futures
Posted 28th November 2018 by Jane Williams
It was a pleasure to have Dirk Gevers involved in our Microbiome Futures project earlier this year. In the following opinion piece, Dirk reflects on the outcomes that went on to be published in Nature Biotechnology.
The original article can be found on Biovox and is republished here with kind permission.
The 6th Microbiome R&D and Business Collaboration Forum: A Summary
Posted 19th November 2018 by Jane Williams
Leaders in the microbiome industry met in San Diego, USA on October 29th and 30th 2018, to dive into the advancements in research and product development that have occurred to date. This summary was authored by Anusha Gandi from Microbiome Insights and the original version can be found on their blog.
Translating Microbiome Futures
Posted 9th November 2018 by Jane Williams
In May of this year, Nature Biotechnology and Global Engage convened a panel of leaders in the microbiome field that included CEOs and CSOs of several microbiome companies, representatives from big pharmas working in the space, and top academics from the New York area and beyond to discuss the current state of the art in human microbiome research and its translation into therapies.
